Feedback / Questions
Oncopore (ruxotemitide) - Verrica
https://www.globenewswire.com/news-release/2025/10/07/3162943/0/en/Verrica-Pharmaceuticals-to-Present-New-Data-on-VP-315-from-its-Phase-2-Trial-in-Basal-Cell-Carcinoma-BCC-at-the-40th-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting.html
Oct 7, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next